Dutch guideline for preventing nosocomial transmission of highly-resistant micro-organisms (HRMO) in long-term care facilities (LTCFs) by Eikelenboom-Boskamp, Andrea et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/207984
 
 
 
Please be advised that this information was generated on 2019-11-08 and may be subject to
change.
GUIDELINES ARTICLE Open Access
Dutch guideline for preventing nosocomial
transmission of highly-resistant micro-
organisms (HRMO) in long-term care
facilities (LTCFs)
Andrea Eikelenboom-Boskamp1* , Jobje Haaijman2, Maria Bos3, Katja Saris1, Else Poot4, Andreas Voss1,5 and On
behalf of the expert group ‘Long-term care facilities’ of the former Dutch Working Party on infection control
Abstract
In 2012, the Dutch Working Party for Infection Control (WIP) issued the first Guideline for prevention of transmission
of highly-resistant micro-organisms (HRMO) in Hospitals. The next step was to focus on long-term care facilities
(LTCFs) both for nursing homes as for small-scale living facilities with nursing home care. These facilities providing
care for residents with functional disabilities, chronical illnesses and cognitive disorders, such as dementia. The
objective was to adapt the Guideline for prevention of transmission of HRMO in hospitals to LTCFs with a strong
accent on living conditions and social interactions.
Residents of LTCFs may be carriers of HRMO over a long period of time and most of the residents of the LTCF stay
for extended periods of time. To respect individual living circumstances and to prevent unnecessary limitations in
the social life of the residents due to the use of isolation measures, the WIP has chosen to describe infection
control precautions per individual micro-organism instead of a ‘one size fits all’ method. The term “isolation” was
therefore replaced by the term “additional” precautions. This guideline describes the screening policies for residents
in LTCFs, definition and detection of HRMO carriage, standard and additional infection control precautions for
HRMO positive residents, documentation and communication of HRMO carriage and discontinuation of additional
infection control precautions. It also describes contact tracing of HRMO, environmental control/investigation,
surveillance of HRMO and what is important when there is an outbreak.
Keywords: Highly-resistant micro-organisms, HRMO, Antibiotic resistance, Antimicrobial resistance, Long-term care
facilities, LTCF, Infection control precautions, Guidelines
Introduction
Antimicrobial resistance (AMR) is a worldwide threat to
healthcare as common empiric antibiotics may no longer
be effective to treat infections, including those that are
life-threatening. Consequently, AMR may result in in-
creased morbidity, mortality and cost of healthcare.
The World Health Organization (WHO) issued the
Antimicrobial Resistance, Global Report on surveillance
in 2014. This report summarizes all information on
AMR and speaks of alarming levels of AMR in many
parts of the world [1]. In the Netherlands, AMR has,
with a few exceptions, stayed on the same level from
2010 to 2015 [2]. Still, to control the increase in AMR,
antibiotic should be used wisely and infection control
precautions should be installed to prevent transmission
of Highly Resistant Micro-Organisms (HRMO).
In 2012, the – by now former - Dutch Working Party
for Infection Control (WIP) issued the first Guideline
for prevention of transmission of HRMO in Hospitals [3,
4]. This guideline provides definitions for classification
of HRMO and recommendations on surveillance, isola-
tion precautions for patients and advice on outbreak
management. It is currently implemented in Dutch hos-
pitals. The next step was to focus on long-term care
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facilities (LTCFs), providing care for residents with
functional disabilities, chronical illnesses and cognitive
disorders, such as dementia. In the Netherlands, these
residents are in the care of an “elderly care physician”,
a distinct medical specialization, exclusively working in
LTCFs. Within the structure of the WIP, a so-called
“Expert group LTCFs” was established, with profes-
sionals working (partially) in/for LTCFs. The expert
group was tasked with the development of multiple
Infection prevention and control guidelines, the first of
which was ‘the prevention of transmission of HRMO in
LTCFs’.
Based on the Guideline for prevention of transmis-
sion of HRMO in hospitals, the ultimate goal was to
adjust this guideline [5] to the living circumstances in
LTCFs. This concerns all forms of nursing home care
within institutions such as nursing homes or small-
scale living facilities with the exception of geriatric
departments of a hospital. These facilities have a
strong emphasis on living conditions and social inter-
actions. As residents of LTCFs may be carriers of
HRMO over a long period of time [6] and as most of
the residents of the LTCF stay for longer periods of
time, infection control precautions may have a nega-
tive impact on the quality of life [7]. In order to re-
spect individual living circumstances and to prevent
unnecessary limitations in social life, the WIP has
chosen to describe infection control precautions per
individual micro-organism instead of a ‘one size fits
all’ method. In addition, the term “isolation” was re-
placed by the term “additional precautions”.
This guideline focusses on the control of HRMO and
not for control of Methicillin-resistant Staphylococcus
aureus (MRSA) for which a separate guideline is avail-
able in the Netherlands.
Screening policies for residents in long-term care
facilities
When a resident is admitted to a LTCF and has stayed in a
healthcare facility outside the Netherlands, HRMO screen-
ing must be initiated under the following circumstances:
 When the resident was admitted to a foreign health
care facility (outside the Netherlands, the Caribbean
islands not included) in the 2 months prior to
admission to the LTCF and
 When the duration of admission in a foreign health
care facility was longer than 24 h
It is also advised to test a resident for HRMO carriage
if the resident is transferred from a ward or small-scale
living group within the healthcare facility or another
healthcare facility with an ongoing HRMO outbreak
within the Netherlands.
Definition and detection of HRMO carriage
The definition of HRMO is determined by the micro-or-
ganism and the specific antibiotic where the micro-or-
ganism has shown resistance to. The criteria for HRMO
are based on the guideline “Laboratory detection of
highly resistant microorganisms (HRMO)” of the Dutch
society for Medical Microbiology [8]. This way, the def-
inition of HRMOs are consistent with the established
HRMO guideline for hospitals, making adequate infor-
mation exchange easier [3, 4].
Three main groups of HRMO are distinguished: highly
resistant Enterobacteriaceae (Table 1); highly resistant
Gram-negative nonfermenters (Table 2), and highly re-
sistant Gram-positive bacteria (Table 3).
To detect residents that carry HRMO, specific cultures
have to be taken (Table 4).
Standard and additional infection control precautions for
HRMO positive residents
In general, when giving physical care to residents,
healthcare workers (HCWs) should always take standard
precautions, such as adequate hand hygiene. These are
meant to reduce the risk of transmission of pathogens
from both known and unknown sources. The standard
precautions are the minimal precautions a HCW must
take in the care of all residents [9–11].
The additional infection control precautions are de-
scribed in Table 5a and b. In order to be clear and
undisputable, all precautions are listed, including the
standard precautions such as hand hygiene.
Documentation and communication of HRMO carriage
The documentation of the HRMO carriage is of utmost
importance. Without knowing this, precautions to pre-
vent transmission in the LTCF and other healthcare fa-
cilities (HCFs) cannot be taken. Therefore, all HCW
involved, including those who are involved outside the
LTCF (e.g. treating physicians in a hospital, primary care
physicians), should be informed of the HRMO status of
the resident. In addition, the HRMO status should be
documented in the (E) Health records for (para) medical
and nursing staff.
Before transferring a HRMO positive resident to an-
other ward/small-scale living group within the facility, or
another facility, or before visiting e.g. an outpatient de-
partment, all those providing care should be informed
about the HRMO status.
When a HRMO positive resident is re-admitted to a
LTCF and there have not been 2 sets of negative HRMO
cultures according to the rules mentioned in the section
“Discontinuation of additional infection control precau-
tions” below, additional precautions should be taken.
The HRMO carriers themselves/or the first contact
person and their caregivers should be notified about
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the HRMO status in order to receive needed informa-
tion with regard to the consequences as well as being
able to apply adequate infection control measures. It
is necessary that the physician-in-charge and other
HCWs of the LTCF have the opportunity to consult a
medical microbiologist and/or an infection control
practitioner for advice regarding the prevention of
transmission, diagnostics and treatment for HRMO
positive residents.
Discontinuation of additional infection control
precautions
Based on experience from earlier outbreaks and expert
opinion, additional infection control precautions can be
discontinued in the following cases:
 Resident, suspected for HRMO carriage:
○ If the HRMO screening cultures (Table 1) are
negative, additional precautions can be
discontinued. The resident should be without
antibiotic treatment for at least 48 h before
cultures are taken.
 Resident, HRMO positive
○ If a resident is carrier of Enterobacteriaceae,
(Extended-spectrum beta-lactamase (ESBL)
included, Carbapenemase-producing
Enterobacteriaceae (CPE) excluded), Acinetobacter
species, Pseudomonas aeruginosa, Stenotrophomonas
maltophilia and Streptococcus pneumonia (PRP),
then additional precautions can be discontinued if at
least 2 sets of HRMO screening cultures (taken at
least 24 h apart) are negative.
○ If a resident is carrier of CPE or vancomycin-
resistant Enterococcus faecium (VRE), additional
precautions can be discontinued if at least 2 sets
of cultures are negative, at least 1 year apart.
Contact tracing of HRMO
Contact tracing is recommended in case of unexpected
HRMO positive residents. When a contact of the HRMO
positive index appears to be HRMO positive too, it could
be due to a single transmission event or it can be the re-
sult of broad transmission within a facility. In order to
detect and prevent further transmission, contact tracing
is recommended for all HRMO, possibly with an excep-
tion for ESBL positive Enterobacteriaceae or for
Enterobacteriaceae resistant for Quinolones and Amino-
glycosides. These two HRMOs are commonly found in
the Dutch population with a prevalence of up to 8–10%
in patients seeing a general practitioner [12].
The scale of the contact tracing is determined by the
elderly care physician in collaboration with the medical
microbiologist and/or infection control practitioner. In
most cases, all residents who have been in contact with
the HRMO positive resident will be cultured for HRMO
carriage (see Table 4). Additional precautions can be
postponed until the culture results from the first investi-
gation are known. Directly changing precautions have
much impact for the residents and HCWs and according
to expert opinion is not advisable until transmission ac-
tually has been proven. If residents are transferred to an-
other ward or HCF, it is advised to take additional
precautions while waiting for culture results. Residents
who are already discharged to their home-setting, will
initially not be cultured unless in the first investigation
HRMO positive residents are detected.
Contact tracing is also recommended if HRMO car-
riage is confirmed with a HRMO suspected resident and
it is known that the additional precautions have not
Table 1 Definition of highly resistant Enterobacteriaceae
Gram-negative rods ESBL Carbapenemase Aminoglycosides Quinolones
Enterobacteriaceae A A B B
ESBL extended-spectrum beta-lactamase; A: presence of ESBL or Carbapenemase is sufficient to define the microorganism as highly resistant; B: resistance against
both antibacterial agents from the two indicated groups is required to define the microorganism as highly resistant
Table 2 Definition of highly resistant gram-negative nonfermenters
Gram-negative
nonfermenters
Carbapenemase Aminoglycosides Quinolones Ceftazidime Piperacillin Co-trimoxazole
Acinetobacter spp. A B Ba n/a n/a n/a
Stenotrophomonas
maltophilia
n/a n/a n/a n/a n/a A
Pseudomonas
aeruginosa
C C C C C n/a
aonly Ciprofloxacin and/or Levofloxacin, due to the intrinsic resistance of Acinetobacter species for norfloxacin; A: Carbapenemase or resistance against an
antibacterial agent from the indicated group is sufficient to define the microorganism as highly resistant; B: resistance against antibacterial agents from at least
two indicated groups is required to define the microorganism as highly resistant; C: resistance against antibacterial agents from at least three of the indicated
groups is required to define the microorganism as highly resistant; n/a: not applicable
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adequately been performed in the time between cultur-
ing and results. In that time HRMO transmission could
have taken place.
Contact tracing among HCWs is not indicated. HCW,
if at all, are only transient carriers of HRMO. In addition
- and in contrast to MRSA - possibilities for
decolonization treatment of HRMOs is limited and not
routinely used.
Environmental control/investigation
Initially, culturing the environment to detect a source of
the HRMO is not indicated. If, however, during an out-
break with HRMO transmission persists, environmental
culturing may be considered to determine a source of
the outbreak.
Surveillance of HRMO
Evaluation of the local and regional epidemiology of
HRMO provides knowledge in the, sometimes rapidly
changing, evolution in this area.
Performing surveillance on a local and regional level,
by exchanging on a regular basis HRMO data from rou-
tine diagnostics, can be very helpful to determine if there
is an indication of an increasing level of HRMO. At
present, gathering and combining data to receive insight
into the regional epidemiology is a task for the Dutch re-
gional networks, initiated by the ministry of health, to
combat AMR. To have unbiased surveillance data (at
least once a year) point-prevalence studies among the
residents of the LTCF should be performed by trained
professionals to determine local levels and possible
transmission of HRMO in the facility.
Outbreak
A situation is considered to be an outbreak when 2 or
more residents have the same HRMO and the presence
of an epidemiological link between them.
During an outbreak, it is important to maintain and
highlight the standard precautions and additional pre-
cautions specific for that kind of HRMO (as described in
Table 5b).
It is strongly advisable to install an Outbreak Management
Team. This multidisciplinary team consists an elderly
care physician, medical microbiologist, infection con-
trol practitioner, staff members of the wards involved
(both nursing and medical), member of the manage-
ment team and professional of the Local Health
Authority.
This team which will take care of the arising issues
such as decisions on additional infection control precau-
tions, adjustment of antibiotic therapy, communication
within and outside of the LTCF where the outbreak
takes place and alert national authorities of this specific
outbreak.
When despite tightening up infection prevention pre-
cautions, further transmission takes place, confirmation
of clonal relationship between the strains or plasmids by
molecular typing needs to be done [13].
Discussion
There are limitations to this guideline for HMRO car-
riage in long term care settings.
Table 3 Definition of highly resistant gram-positive bacteriaa
Gram-positive bacteria Penicillins Vancomycin
Streptococcus pneumoniae A A
Enterococcus faecium B B
a: MRSA not included; A: resistance against an antibacterial agent from the
indicated group is sufficient to define the micro-organism as highly resistant;
B: resistance against both antibacterial agents from the two indicated groups
is required to define the microorganism as highly resistant
Table 4 Diagnostic screening procedure for residents suspected for HRMO carriage in LTCF
Micro-organism/Indication Standard Culturesa Additional cultures (when indicated)a,b
Enterobacteriaceae (ESBL and CPE inclusive) Rectal swab or stool sample Wound swab, sputum sample, urine sample
Acinetobacter species Rectal swab or stool sample and sputum
sample or oropharyngeal swabc
Wound swab, urine sample
Stenotrophomonas maltophilia Rectal swab or stool sample and sputum
sample or oropharyngeal swabc
Wound swab, urine sample
Pseudomonas aeruginosa Rectal swab, stool sample and sputum
sample or oropharyngeal swabc
Wound swab, urine sample
Streptococcus pneumoniae Sputum sample or oropharyngeal swabc –
Enterococcus faecium Rectal swabs or stool samples Wound swabs, sputum samples, urine samples
When resident is transferred from health care
facility outside the Netherlands
Rectal swab or stool sample and sputum
sample or oropharyngeal swabc
Wound swab, sputum sample, urine sample
aSingle swab/sample from the stated site, excepting for Enterococcus faecium. Standard and additional cultures for Enterococcus faecium: five swabs/samples on
five consecutive days
bDepending on clinical presentation of the signs and symptoms of resident: ▪ culture of sputum when resident has a persistent cough ▪ culture of wound if present
▪ urine culture when urinary tract catheter is in place
c Preferably sputum sample. If sputum sample cannot be obtained, collect oropharyngeal swab
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First, the absolute risk of transmission of HRMO
within the Dutch LTCFs (as defined in the guideline) is
not known. However, there is a growing understanding
of the potential for transmission of HRMO in the LTCF.
In 2016, den Dool et al. used mathematical modelling to
estimate the contribution of nursing homes in the dis-
persal of pathogens over the healthcare network in the
Netherlands. They concluded that nursing homes have
the potential to drive and sustain epidemics across this
network and that infection control efforts and surveil-
lance systems should also be targeted at those LTCFs
[14]. Recent research in Dutch LTCFs showed that, al-
though in absolute numbers the percentage of HRMO is
low (4.2% Escherichia coli ESBL carriage among resi-
dents), the large variation of HRMO presence between
facilities (1–33%) warrants cautious surveillance [15].
Secondly, it is not known how long a resident remains
colonised with HRMO. Research shows that carriage can
persist over years, depending on the micro-organism
[15]. The guidance for the decision to discontinue infec-
tion control precautions is therefore based on expert
opinion. Although research indicates that there might be
predisposing factors for prolonged carriage, more re-
search is needed to determine when to discontinue pre-
cautions and consider HRMO carriage as ended in long-
term care. Despite the lack of studies that show the ef-
fect of monitoring of the HRMO carriage of a resident
and its consequences in LTCFs, it is logical to assume
that these measures are effective to prevent the trans-
mission of HRMO.
Last but not least, it is not known whether the pro-
posed actions in the LTCF on prevention of transmis-
sion of HRMO, are equally effective and achievable for
the various groups of residents in such facilities, such as
e.g. psychogeriatric residents. However, given the rising
evidence for spreading of HRMO within the LTCF set-
tings, this is a first step in developing guidelines for pre-
vention of transmission of HRMO. Over the course of
time, with leaders in both infection control and LTCFs,
further guidance should be provided, while the absolute
risk of transmission and harm as opposed to the adverse
events related to additional precautions, such as reduced
psychological wellbeing, resident safety and satisfaction
in residential care [7].
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